Viewing Study NCT02113293


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2026-03-05 @ 8:50 AM
Study NCT ID: NCT02113293
Status: COMPLETED
Last Update Posted: 2014-05-20
First Post: 2014-04-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CyclASol® Phase 1 Study
Sponsor: Novaliq GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module